HLI · Houlihan Lokey, Inc.
Price & Indicators
Up next
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| # of Closed transactions (Corporate Finance) | 127 | Three Months Ended June 30, 2026 | — |
| # of Closed transactions (Financial Restructuring) | 23 | Three Months Ended June 30, 2026 | — |
|
|
|||
| # of Fee Events | 1,042 | Three Months Ended June 30, 2026 | — |
|
|
|||
| # of Managing Directors (Corporate Finance) | 260 | Three Months Ended June 30, 2026 | — |
| # of Managing Directors (Financial and Valuation Advisory) | 47 | Three Months Ended June 30, 2026 | — |
|
|
|||
| # of Managing Directors (Financial Restructuring) | 58 | Three Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted compensation ratio non-GAAP | 61.5% | Three Months Ended June 30, 2026 | — |
|
|
|||
| Adjusted effective tax rate non-GAAP | 12.6% | Three Months Ended June 30, 2026 | — |
|
|
|||
| Share repurchases | 348K | Three Months Ended June 30, 2026 | — |
|
|
|||
| # of Closed transactions | 177 | Q3 FY2026 | — |
| # of Managing Directors | 238 | Q3 FY2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Capital Markets — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
HLI
this stock
Houlihan Lokey, Inc.
|
$8.99B | -26.1% | +9.5% | 21.6 | 3.1% |
|
MS
Morgan Stanley
|
$341.38B | +22.4% | +5.5% | 17.6 | 0.8% |
|
GS
Goldman Sachs Group Inc
|
$302.65B | +18.3% | +8.9% | 16.0 | 2.1% |
|
SCHW
Schwab Charles Corp
|
$189.09B | +11.2% | +22.0% | 19.9 | 1.2% |
|
HOOD
Robinhood Markets, Inc.
|
$85.92B | -15.5% | +51.6% | 42.3 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| HLI | -0.3% | -8.1% | -21.1% | +2.5% | -26.1% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -0.7% | -12.5% | -34.9% | -1.4% | -40.0% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.